ADAM17 and gastric cancer: A meta-analysis associated with gastric cancer indicated that ADAM17 might be a tumor marker for poor prognosis in gastric cancer, and high expression of ADAM17 is associated with lymph node metastasis and clinical staging of lymph node metastasis in gastric cancer (15).